glipizide has been researched along with c-peptide in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (38.10) | 18.7374 |
| 1990's | 18 (42.86) | 18.2507 |
| 2000's | 7 (16.67) | 29.6817 |
| 2010's | 1 (2.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bird, DM; Cameron, DP; Ma, A; McIntyre, HD; Patterson, CA | 1 |
| Bitzén, PO; Melander, A; Scherstén, B; Svensson, M; Wåhlin-Boll, E | 1 |
| Cryer, PE | 1 |
| Brodows, RG | 1 |
| Bonadonna, RC; DeFronzo, RA; Groop, LC; Luzi, L; Melander, A; Petrides, A; Ratheiser, K; Simonson, DC; Widén, E | 1 |
| Huupponen, R; Karvonen, I; Rytömaa, K; Sotaniemi, EA; Vierimaa, E; Vuoti, MJ | 1 |
| Reckless, JP; Simpson, HC; Stirling, CA; Sturley, R | 1 |
| Bulow, G; Nygren, A; Sundblad, L; Thunberg, E; Wiechel, KL | 1 |
| Castillo, MJ; Lefèbvre, PJ; Scheen, AJ | 1 |
| Bitzén, PO; Melander, A; Scherstén, B; Wåhlin-Boll, E | 1 |
| DeFronzo, RA; Groop, L; Groop, PH; Luzi, L; Melander, A; Ratheiser, K; Simonson, DC | 1 |
| Boyle, M; Fischer, JS; Kipnes, MS; Schwartz, SL | 1 |
| Castillô, M; Lefèbvre, PJ; Paolisso, G; Scheen, AJ | 1 |
| Melander, A; Nilsson-Ehle, P; Sartor, G; Ursing, D; Wåhlin-Boll, E | 1 |
| Adamson, U; Kollind, M; Lins, PE | 1 |
| Ahrén, B; Lundquist, I; Scherstén, B | 1 |
| Allen, BT; Feinglos, MN; Lebovitz, HE | 1 |
| Fyhrqvist, F; Groop, L; Groop, PH; Melander, A; Tolppanen, EM; Tötterman, KJ; Wåhlin-Boll, E | 1 |
| Lefebvre, PJ; Luyckx, AS; Scheen, AJ | 1 |
| Ahrén, B; Scherstén, B | 1 |
| Nygren, A; Sundblad, L; Wiechel, KL | 1 |
| Almér, LO; Johansson, E; Melander, A; Wåhlin-Boll, E | 1 |
| Groop, L; Tötterman, KJ | 1 |
| Chow, CC; Cockram, CS; Sorensen, JP; Tsang, LW | 1 |
| Grunberger, G; Levy, J; Vandenberg, M | 1 |
| Berelowitz, M; Cefalu, W; Fischette, C; Kourides, IA; Schade, DS; Sutfin, T | 1 |
| Berlin, I; Blacker, C; Cesselin, F; Chalon, S; Fuseau, E; Landault, C; Puech, AJ; Rosenzweig, P | 1 |
| Chan, E; Charles, MA; Lozano, J; Robinson, M; Selam, JL; Woertz, L | 1 |
| Groop, LC; Groop, PH; Melander, A | 1 |
| Barzilai, N; DeFronzo, RA; Groop, L; Groop, PH | 1 |
| Albert, SG; Bernbaum, M; Mooradian, AD; Plummer, S | 1 |
| Ducharme, MP; Halapy, H; Jaber, LA | 1 |
| Feinglos, M; Fischette, CT; Kourides, IA; Shamoon, H; Simonson, DC | 1 |
| McDaniel, PA; Riddle, MC; Tive, LA | 1 |
| Gomis, R; Jones, NP; Patwardhan, RN; Squatrito, S; Wolffenbuttel, BH | 1 |
| Dejgaard, A; Kilhovd, B; Lager, I; Madsbad, S; Mustajoki, P | 1 |
| Burge, MR; Carroll, MF; Izard, A; Riboni, K; Schade, DS | 1 |
| Edeki, T; Nzerue, CM; Thomas, J; Volcy, J | 1 |
| Gaillard, T; Osei, K; Rhinesmith, S; Schuster, D | 2 |
| Carroll, MF; Castro, M; Gutierrez, A; Schade, DS; Tsewang, D | 1 |
| Aguilera, E; Fasano, CJ; Heard, K; O'Malley, GF; Rowden, AK | 1 |
1 review(s) available for glipizide and c-peptide
| Article | Year |
|---|---|
Hypoglycemia of obscure cause.
Topics: C-Peptide; Diagnosis, Differential; Fasting; Glipizide; Humans; Hypoglycemia; Insulin; Male; Medication Errors; Middle Aged | 1992 |
26 trial(s) available for glipizide and c-peptide
| Article | Year |
|---|---|
Chronic sulfonylurea therapy augments basal and meal-stimulated insulin secretion while attenuating insulin responses to sulfonylurea per se.
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Kinetics; Middle Aged; Time Factors | 1992 |
Benefits and risks with glyburide and glipizide in elderly NIDDM patients.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Male | 1992 |
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glipizide; Glucose; Glucose Clamp Technique; Humans; Insulin; Insulin Secretion; Kinetics; Male; Middle Aged; Reference Values; Time Factors | 1991 |
Insulin and sulphonylurea in the therapy of type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Metformin; Middle Aged; Placebos; Random Allocation; Sulfonylurea Compounds | 1990 |
Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol Esters; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glucagon; Glucose Clamp Technique; Glyburide; Glycated Hemoglobin; Humans; Insulin; Lipoproteins; Male; Middle Aged; Sulfonylurea Compounds | 1990 |
The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion.
Topics: Adult; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Sulfonylurea Compounds | 1987 |
Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion.
Topics: Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Glipizide; Glycated Hemoglobin; Humans; Insulin; Lipids; Lipoproteins; Male; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1987 |
Glipizide does not affect absorption of glucose and xylose in diabetics without residual beta-cell function.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glipizide; Glucose Tolerance Test; Humans; Intestinal Absorption; Islets of Langerhans; Sulfonylurea Compounds; Xylose | 1986 |
Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
Topics: Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Erythrocytes; Female; Gastric Inhibitory Polypeptide; Glipizide; Glucagon; Glyburide; Glycosuria; Humans; Insulin; Insulin Resistance; Kinetics; Male; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Female; Glipizide; Humans; Insulin; Male; Middle Aged; Stimulation, Chemical; Sulfonylurea Compounds | 1984 |
Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind Method; Female; Glipizide; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Propranolol; Random Allocation; Sulfonylurea Compounds; Tolbutamide | 1982 |
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Treatment Failure; Triglycerides | 1995 |
Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; C-Peptide; Cholesterol; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Glipizide; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Prospective Studies | 1995 |
Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Female; Glipizide; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Radioimmunoassay | 1994 |
Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Blood Glucose; C-Peptide; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Glipizide; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Indoles; Insulin; Male; Pyrroles; Reference Values | 1994 |
The use of glipizide combined with intensive insulin treatment for the induction of remissions in new onset adult type I diabetes.
Topics: Adult; Age of Onset; Algorithms; Blood Glucose; C-Peptide; Combined Modality Therapy; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glipizide; Glycated Hemoglobin; Humans; Injections, Subcutaneous; Insulin; Male; Remission Induction; Weight Gain | 1993 |
The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.
Topics: Amyloid; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Fasting; Female; Glipizide; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Male; Middle Aged; Placebos; Postprandial Period; Single-Blind Method | 1996 |
The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.
Topics: Biological Availability; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; Retrospective Studies | 1996 |
Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointest
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Digestive System; Dose-Response Relationship, Drug; Fasting; Female; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Placebos; Single-Blind Method; Time Factors | 1997 |
Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise; Exercise Test; Female; Glipizide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; Time Factors | 1997 |
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Triglycerides | 2000 |
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Double-Blind Method; Fasting; Female; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Piperidines | 2001 |
Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
Topics: C-Peptide; Cross-Over Studies; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Obesity; Postprandial Period | 2002 |
Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabet
Topics: Adult; Black People; Blood Glucose; C-Peptide; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Glipizide; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Longitudinal Studies; Male; Middle Aged | 2003 |
Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2003 |
Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.
Topics: Adult; Black or African American; Blood Glucose; Body Composition; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Glipizide; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Models, Biological; Obesity; Risk Factors | 2004 |
15 other study(ies) available for glipizide and c-peptide
| Article | Year |
|---|---|
Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus.
Topics: Blood Glucose; Body Mass Index; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Energy Intake; Glipizide; Humans; Insulin; Insulin Secretion; Linear Models; Time Factors | 1992 |
The effect of glipizide on extraction of insulin by the human cirrhotic and noncirrhotic liver.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Female; Glipizide; Humans; Insulin; Liver; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Sulfonylurea Compounds | 1988 |
Decreased or increased insulin metabolism after glipizide in type II diabetes.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Glipizide; Humans; Insulin; Sulfonylurea Compounds | 1988 |
The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.
Topics: Aged; Biological Availability; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1988 |
Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glipizide; Glucagon; Glucose; Glyburide; Humans; Hyperglycemia; Insulin; Insulin Secretion; Kinetics; Liver; Sulfonylurea Compounds | 1987 |
Effects of short-term insulin therapy upon therapeutic response to glipizide.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Interactions; Female; Glipizide; Glucose; Glycated Hemoglobin; Humans; Insulin; Lipoproteins; Male; Mexico; Middle Aged; Statistics as Topic; Sulfonylurea Compounds; Texas | 1987 |
Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Interactions; Female; Food; Glipizide; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Sulfonylurea Compounds; Terbutaline | 1986 |
Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1985 |
Effect of sulfonylurea on glucose, insulin and C-peptide responses to a meal stimulus in a patient with type 2 diabetes and liver disease.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Food; Glipizide; Glyburide; Humans; Insulin; Liver Diseases; Liver Neoplasms; Sulfonylurea Compounds | 1984 |
Influence of glipizide on hepatic and peripheral insulin exchange after glucose administration.
Topics: Adult; Aged; C-Peptide; Female; Forearm; Glipizide; Glucose; Hepatic Veins; Humans; Insulin; Liver; Male; Middle Aged; Portal Vein; Sulfonylurea Compounds | 1980 |
Influence of sulfonylureas on the secretion, disposal and effect of insulin.
Topics: Aged; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus; Female; Glipizide; Half-Life; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1982 |
The relationship between early insulin release and glucose tolerance in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glipizide; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male | 1993 |
A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin.
Topics: Adult; C-Peptide; Female; Glipizide; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Kinetics; Male; Metabolic Clearance Rate | 1995 |
Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Gastrointestinal Agents; Glipizide; Humans; Hypoglycemia; Hypoglycemic Agents; Kidney Failure, Chronic; Male; Octreotide; Seizures | 2003 |
Quantitative insulin and C-peptide levels among ED patients with sulfonylurea-induced hypoglycemia-a prospective case series.
Topics: Aged; Aged, 80 and over; C-Peptide; Cross-Sectional Studies; Drug Overdose; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Prospective Studies; Sulfonylurea Compounds | 2010 |